Spotlight on the Impact of Precision Medicine in Clinical Trial Development

ACRPtv―Spotlight On… The Impact of Precision Medicine in Clinical Trial Development

ACRPtv

Dr. Kevin Flaherty, Chair, Pulmonary Fibrosis Foundation Registry, and Professor of Medicine at the University of Michigan

Featuring Dr. Kevin Flaherty, Chair, Pulmonary Fibrosis Foundation Registry, and Professor of Medicine at the University of Michigan.

In this January 22, 2021 interview, Flaherty discusses the first clinical trial to apply principles of precision medicine to the treatment of patients with idiopathic pulmonary fibrosis and how the trial overcame Covid-19-related obstacles to enroll its first patient this month.


Donate Today

Your gift to the PFF Registry will enable us to expand patient enrollment and provide even greater access to investigators as they search for a cure for PF.

Your Privacy Matters

The Pulmonary Fibrosis Foundation Registry considers the protection of your privacy to be one of our most important responsibilities. We have set up strict protocols to protect your personal information. To review our policy, click here.

Contact Us

To get in touch with the PFF, please email registry@pulmonaryfibrosis.org.

PFF Registry

Patient Powered. Data Driven. Research Results.